Vivos Therapeutics Inc. (NASDAQ:VVOS) saw its stock soar by 90% following a major regulatory win: the company’s VidaSleep ...

Vivos’ portfolio of cutting-edge oral appliances offer a proprietary, clinically effective OSA solution that is nonsurgical, ...

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...

Woodland Heights Medical Center is committed to helping patients get a better night's sleep, offering a surgical treatment ...

With more than 1 in 10 Americans suffering from obstructive sleep apnea putting them at increased risk of heart problems and ...